+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Breast Imaging Market - Forecasts from 2025 to 2030

  • PDF Icon

    Report

  • 140 Pages
  • June 2025
  • Region: Global
  • Knowledge Sourcing Intelligence LLP
  • ID: 6113780
The Global Breast Imaging Market is expected to grow from USD 5.075 billion in 2025 to USD 7.394 billion in 2030, at a CAGR of 7.82%.

Increasing Breast Cancer Incidence and Awareness

Breast cancer remains one of the most prevalent cancers affecting women globally, as noted by the World Health Organization, with significant impact in both developed and developing nations. Low survival rates are primarily due to inadequate early detection programs and limited awareness of routine screenings, leading to late-stage diagnoses. The growing incidence of breast cancer is driving heightened awareness among women about the importance of timely checkups, which significantly reduce risks through early detection. This shift is increasing demand for advanced breast imaging equipment, fueling market expansion as healthcare providers prioritize technologies that enhance diagnostic accuracy and patient outcomes.

Adoption of Advanced Imaging Techniques

The market is benefiting from the adoption of innovative breast imaging methods that improve diagnostic efficiency. Techniques such as molecular breast imaging (MBI), contrast-enhanced mammography (CEM), positron emission mammography (PEM), electrical impedance testing (EIT), and optical imaging tests are gaining traction. MBI, a nuclear medicine approach, involves injecting a chemical tracer and using a specialized camera to evaluate breast abnormalities, particularly for women with dense breasts or abnormal mammograms. CEM uses iodine-based contrast dye to highlight abnormal breast tissue, offering a cost-effective alternative to MRI. PEM, akin to PET scans, employs radioactive sugar to detect small cancer cell clusters. EIT leverages differences in electrical conductivity between cancerous and normal cells, while optical imaging analyzes light transmission to monitor cancer growth. These methods, despite challenges like radiation exposure in MBI and PEM, are driving the development of enhanced imaging equipment, contributing to market growth by enabling more precise diagnostics.

Technological Advancements

Continuous innovation in breast imaging technologies is a key growth driver. Advanced systems with improved capabilities for detecting and monitoring cancer cell spread are being developed, enhancing diagnostic precision and workflow efficiency. These advancements are expected to increase adoption across healthcare settings, as manufacturers introduce diverse, high-performance imaging solutions. The focus on sophisticated equipment that delivers faster, more accurate results is anticipated to propel market growth over the forecast period, as providers seek to meet rising demand for early and effective breast cancer detection.

Market Challenges

Despite technological progress, certain imaging techniques, such as MBI and PEM, involve radiation exposure, limiting their use in routine screening. Emerging methods like EIT and optical imaging require further clinical validation and infrastructure investment, posing barriers to widespread adoption. These challenges highlight the need for ongoing research to balance diagnostic efficacy with patient safety and accessibility.

Regional Outlook

North America is expected to maintain a dominant market share through the forecast period, driven by the high prevalence of breast cancer and increasing mortality rates, which are prompting greater investment in advanced imaging solutions and awareness campaigns. The Asia Pacific region is poised to expand its market share, supported by initiatives to enhance diagnostic facilities and healthcare infrastructure. These regional trends reflect varying healthcare priorities and investments, shaping the market’s growth trajectory.

Conclusion

The breast imaging market is on a strong growth path, driven by rising breast cancer cases, growing awareness of early detection, and innovative imaging technologies. North America leads due to high disease prevalence and investment, while Asia Pacific is set to grow through improved diagnostic infrastructure. Despite challenges like radiation risks and adoption barriers, advancements in MBI, CEM, PEM, EIT, and optical imaging are expanding market opportunities. Industry experts should note the critical role of technological innovation and regional dynamics in shaping the market’s future.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others).

Segmentation:

By Technology

  • Mammography
  • Ultrasound
  • Magnetic Resonance Imaging (MRI)
  • Nuclear Imaging
  • Others

By Procedure

  • Screening Mammography
  • Diagnostic Mammography
  • Breast Tomosynthesis
  • Breast Ultrasound
  • Breast MRI
  • Others

By End-User

  • Hospitals
  • Diagnostic Centers
  • Research Laboratories

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Others
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Indonesia
  • Thailand
  • Others

Table of Contents

1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. BREAST IMAGING MARKET BY TECHNOLOGY
5.1. Introduction
5.2. Mammography
5.3. Ultrasound
5.4. Magnetic Resonance Imaging (MRI)
5.5. Nuclear Imaging
5.6. Others
6. BREAST IMAGING MARKET BY PROCEDURE
6.1. Introduction
6.2. Screening Mammography
6.3. Diagnostic Mammography
6.4. Breast Tomosynthesis
6.5. Breast Ultrasound
6.6. Breast MRI
6.7. Others
7. BREAST IMAGING MARKET BY END-USER
7.1. Introduction
7.2. Hospitals
7.3. Diagnostic Centers
7.4. Research Laboratories
8. BREAST IMAGING MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. United Kingdom
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Israel
8.5.4. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Australia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. GE Healthcare
10.2. Hologic, Inc.
10.3. Siemens Healthineers AG
10.4. Koninklijke Philips N.V.
10.5. Fujifilm Holdings Corporation
10.6. Canon Medical Systems Corporation
10.7. Dilon Technologies, Inc.
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations

Companies Mentioned

  • GE Healthcare
  • Hologic, Inc.
  • Siemens Healthineers AG
  • Koninklijke Philips N.V.
  • Fujifilm Holdings Corporation
  • Canon Medical Systems Corporation
  • Dilon Technologies, Inc.

Table Information